Home
/
NEOGEN CORP
/
Financials
/
Quarterly
NEOGEN CORP — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that NEOGEN CORP filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Feb 28, 2026
$211.20M
Apr 9, 2026
Q2
2026
Nov 30, 2025
$224.69M
Jan 8, 2026
Q1
2026
Aug 31, 2025
$209.19M
Oct 9, 2025
Q3
2026
Feb 28, 2025
$221.00M
Apr 9, 2026
Q2
2026
Nov 30, 2024
$231.26M
Jan 8, 2026
Q1
2026
Aug 31, 2024
$216.96M
Oct 9, 2025
Q3
2025
Feb 29, 2024
$228.81M
Apr 9, 2025
Q2
2025
Nov 30, 2023
$229.63M
Jan 15, 2025
Q1
2024
Aug 31, 2023
$228.99M
Oct 10, 2024
Q3
2024
Feb 28, 2023
$218.26M
Apr 9, 2024
Q2
2024
Nov 30, 2022
$230.03M
Jan 9, 2024
Q1
2024
Aug 31, 2022
$132.35M
Oct 10, 2023
Q3
2023
Feb 28, 2022
$128.24M
Apr 4, 2023
Q2
2023
Nov 30, 2021
$130.52M
Jan 9, 2023
Q1
2023
Aug 31, 2021
$128.31M
Sep 30, 2022
Q3
2022
Feb 28, 2021
$116.71M
Apr 1, 2022
Q2
2022
Nov 30, 2020
$115.00M
Dec 30, 2021
Q1
2022
Aug 31, 2020
$109.33M
Sep 30, 2021
Q3
2021
Feb 29, 2020
$99.87M
Mar 31, 2021
Q2
2021
Nov 30, 2019
$107.80M
Dec 29, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Feb 28, 2018
$95.89M
Mar 29, 2018
Q2
2018
Nov 30, 2017
$101.82M
Jan 5, 2018
Q1
2018
Aug 31, 2017
$95.26M
Sep 29, 2017
Q3
2018
Feb 28, 2017
$88.39M
Mar 29, 2018
Q2
2018
Nov 30, 2016
$90.72M
Jan 5, 2018
Q1
2018
Aug 31, 2016
$83.65M
Sep 29, 2017
Q3
2017
Feb 29, 2016
$76.73M
Mar 31, 2017
Q2
2017
Nov 30, 2015
$79.61M
Dec 29, 2016
Q1
2017
Aug 31, 2015
$74.86M
Sep 30, 2016
Q3
2016
Feb 28, 2015
$68.41M
Mar 31, 2016
Q2
2016
Nov 30, 2014
$68.46M
Jan 8, 2016
Q1
2016
Aug 31, 2014
$67.60M
Sep 30, 2015
Q3
2015
Feb 28, 2014
$62.00M
Apr 1, 2015
Q2
2015
Nov 30, 2013
$59.60M
Dec 30, 2014
Q1
2015
Aug 31, 2013
$58.55M
Sep 30, 2014
Q3
2014
Feb 28, 2013
$51.06M
Apr 4, 2014
Q2
2014
Nov 30, 2012
$50.74M
Jan 9, 2014
Q1
2014
Aug 31, 2012
$49.73M
Sep 30, 2013
Q3
2013
Feb 29, 2012
$44.91M
Mar 28, 2013
Q2
2013
Nov 30, 2011
$44.89M
Dec 28, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Feb 28, 2026
($17.00M)
Apr 9, 2026
Q2
2026
Nov 30, 2025
($15.92M)
Jan 8, 2026
Q1
2026
Aug 31, 2025
$36.34M
Oct 9, 2025
Q3
2026
Feb 28, 2025
($10.90M)
Apr 9, 2026
Q2
2026
Nov 30, 2024
($456.28M)
Jan 8, 2026
Q1
2026
Aug 31, 2024
($12.61M)
Oct 9, 2025
Q3
2025
Feb 29, 2024
($2.02M)
Apr 9, 2025
Q2
2025
Nov 30, 2023
($3.49M)
Jan 15, 2025
Q1
2024
Aug 31, 2023
$1.50M
Oct 10, 2024
Q3
2024
Feb 28, 2023
$8.19M
Apr 9, 2024
Q2
2024
Nov 30, 2022
($41.84M)
Jan 9, 2024
Q1
2024
Aug 31, 2022
$5.21M
Oct 10, 2023
Q3
2023
Feb 28, 2022
$5.44M
Apr 4, 2023
Q2
2023
Nov 30, 2021
$10.83M
Jan 9, 2023
Q1
2023
Aug 31, 2021
$17.08M
Sep 30, 2022
Q3
2022
Feb 28, 2021
$13.38M
Apr 1, 2022
Q2
2022
Nov 30, 2020
$15.89M
Dec 30, 2021
Q1
2022
Aug 31, 2020
$15.86M
Sep 30, 2021
Q3
2021
Feb 29, 2020
$12.20M
Mar 31, 2021
Q2
2021
Nov 30, 2019
$16.28M
Dec 29, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Feb 28, 2026
($3.30M)
Apr 9, 2026
Q2
2026
Nov 30, 2025
($5.38M)
Jan 8, 2026
Q1
2026
Aug 31, 2025
($16.09M)
Oct 9, 2025
Q3
2026
Feb 28, 2025
$5.40M
Apr 9, 2026
Q2
2026
Nov 30, 2024
($457.48M)
Jan 8, 2026
Q1
2026
Aug 31, 2024
$2.26M
Oct 9, 2025
Q3
2025
Feb 29, 2024
$12.02M
Apr 9, 2025
Q2
2025
Nov 30, 2023
$14.47M
Jan 15, 2025
Q1
2024
Aug 31, 2023
$19.14M
Oct 10, 2024
Q3
2024
Feb 28, 2023
$15.68M
Apr 9, 2024
Q2
2024
Nov 30, 2022
($7.66M)
Jan 9, 2024
Q1
2024
Aug 31, 2022
$6.06M
Oct 10, 2023
Q3
2023
Feb 28, 2022
$6.38M
Apr 4, 2023
Q2
2023
Nov 30, 2021
$12.47M
Jan 9, 2023
Q1
2023
Aug 31, 2021
$21.75M
Sep 30, 2022
Q3
2022
Feb 28, 2021
$15.77M
Apr 1, 2022
Q2
2022
Nov 30, 2020
$19.25M
Dec 30, 2021
Q1
2022
Aug 31, 2020
$18.90M
Sep 30, 2021
Q3
2021
Feb 29, 2020
$13.04M
Mar 31, 2021
Q2
2021
Nov 30, 2019
$18.27M
Dec 29, 2020